# Society of Nuclear Medicine and Molecular Imaging

Source: https://onco.cc/institutions/snmmi/  
OnCo record `snmmi` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The Society of Nuclear Medicine and Molecular Imaging represents US nuclear medicine and publishes the Journal of Nuclear Medicine; its annual meeting is where new PET tracers and radioligand therapy results are presented, and its procedure standards guide PSMA and somatostatin receptor imaging.

## Summary

Founded in 1954 as the Society of Nuclear Medicine, SNMMI represents physicians, technologists and scientists in nuclear medicine and molecular imaging and publishes the Journal of Nuclear Medicine and the Journal of Nuclear Medicine Technology. Its annual meeting is where new PET tracers and radioligand therapy results are presented, its procedure standards and appropriate use criteria guide PSMA PET, FDG PET and somatostatin receptor imaging, and its Clinical Trials Network qualifies sites and scanners for multicentre trials. SNMMI runs the Mars Shot fund for radiopharmaceutical research, the Value Initiative on access and reimbursement, and dosimetry and radiation safety education, and it partners with EANM on joint guidelines and the theranostics centres of excellence programme.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: SNMMI; Society of Nuclear Medicine
- City: Reston, VA, US
- Type: consortium
- Website: https://www.snmmi.org

## Sources

- SNMMI: https://www.snmmi.org

## Connected records

- collections: [SNMMI Annual Meeting](https://onco.cc/collections/src-snmmi/)
- fronts: [Imaging](https://onco.cc/fronts/imaging/), [Radiopharmaceuticals & Theranostics](https://onco.cc/fronts/radiopharma/)
- technologies: [FDG PET](https://onco.cc/technologies/fdg-pet/), [PET (positron emission tomography)](https://onco.cc/technologies/pet/), [PET/CT](https://onco.cc/technologies/pet-ct/), [PSMA PET](https://onco.cc/technologies/psma-pet/), [Radioligand therapy (beta emitters)](https://onco.cc/technologies/radioligand-therapy/), [SPECT & bone scan](https://onco.cc/technologies/spect/), [Targeted alpha therapy](https://onco.cc/technologies/targeted-alpha-therapy/)
- drugs: [Lutetium-177 dotatate](https://onco.cc/drugs/lutathera/), [Lutetium-177 vipivotide tetraxetan](https://onco.cc/drugs/pluvicto/), [Piflufolastat F-18 / Pylarify TruVu](https://onco.cc/drugs/pylarify/)
- institutions: [American Society for Radiation Oncology](https://onco.cc/institutions/astro/), [European Association of Nuclear Medicine](https://onco.cc/institutions/eanm/)
- terms: [Dosimetry](https://onco.cc/terms/dosimetry/), [Standardised uptake value (SUV)](https://onco.cc/terms/suv/), [Theranostics](https://onco.cc/terms/theranostics/)
- people: [Virginia Pappas](https://onco.cc/people/virginia-pappas/), [Wolfgang A. Weber](https://onco.cc/people/wolfgang-weber/)

---
JSON: https://onco.cc/api/v1/entities/snmmi.json